Dr. Kerdel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1400 NW 12th Ave
Ste 4
Miami, FL 33136Phone+1 305-324-2110Fax+1 305-325-0919
Education & Training
Massachusetts General Hospital/Beth Israel Deaconess Medical Center/Brigham and Women's HospResidency, Dermatology, 1981 - 1984
Guy's, King's and St Thomas' School of Medical EducationClass of 1979
Certifications & Licensure
FL State Medical License 1987 - 2026- American Board of Dermatology Dermatology
- American Board of Dermatology Dermatological Immunology/Diagnostic & Laboratory Immunology
Awards, Honors, & Recognition
- Top Doctors:South Florida Castle Connolly, 2012
- Top Doctors: Florida Castle Connolly, 2000
- Super Doctor SuperDoctors.com
- Join now to see all
Clinical Trials
- Use of KC706 for the Treatment of Pemphigus Vulgaris Start of enrollment: 2007 Nov 01
- Study to Assess the Safety and Efficacy of Infliximab to Treat Hidradenitis Suppurtativa Start of enrollment: 2005 Jun 01
- The Safety and Efficacy of Etanercept (Enbrel®) for the Treatment of Discoid Lupus Erythematosus Start of enrollment: 2008 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- 97 citationsEfficacy and safety of briakinumab vs. etanercept and placebo in patients with moderate to severe chronic plaque psoriasisAlice B. Gottlieb, C. Leonardi, Francisco A. Kerdel, Stephanie L Mehlis, M. Olds
The British Journal of Dermatology. 2011-09-01 - 583 citationsPhase 3 Studies Comparing Brodalumab with Ustekinumab in PsoriasisMark Lebwohl, Bruce Strober, Alan Menter, Kenneth B. Gordon, Jolanta Weglowska
The New England Journal of Medicine. 2015-09-30 - 10 citationsThree-year U.S. pharmacovigilance report of brodalumab.Mark Lebwohl, Craig L. Leonardi, April W. Armstrong, Nicole Rawnsley, Binu Alexander
Dermatologic Therapy. 2021-08-21
Press Mentions
Ortho Dermatologics’ Bryhali Lotions Performs Well in Two Phase 3 Psoriasis TrialsOctober 2nd, 2018
Biologics Offer Promise for Hidradenitis Suppurativa TreatmentFebruary 19th, 2018
XBiotech Announces First Patient in Phase 2 Study Evaluating MABp1 in Patients with Atopic DermatitisMay 23rd, 2018
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
